Most Favored Patient issues statement on President Trump’s 2026 State of the union address

Washington, D.C. — February 25, 2026 — Most Favored Patient, an initiative of Unleash Prosperity Now, applauds President Trump’s remarks on reining in big health insurers during his State of the Union address and urges the Trump administration to move forward with free-market, patient-centered solutions, not price controls, to reform U.S. health care.

Health insurance conglomerates are driving up health care costs and patients suffer the consequences. Yet, the Democrats have aligned with the health insurers and supported them with vast subsidies.  Their stock prices have soared as premiums, deductibles, and co-pays rise for hardworking Americans.

We commend President Trump for noting that price transparency is critical for any health care solution. Congress and the president took a major step toward restoring transparency to the health care system by passing and signing pharmacy benefit manager (PBM) reform into law. For too long, insurers have used their PBM divisions to profit from higher prices at the expense of taxpayers and patients.  This law is an important start, but there is still work to be done.

The MFP blueprint offers a path forward for U.S. health care reform that advances the promising aspects of President Trump’s agenda without adopting price controls.  History tells us that price controls cause shortages.  Health care policy should encourage more cures, and better health not price controls or rationing.

Recent MFP polling shows that 92% of voters support the president's proposal to require full price transparency in health care.  91% support allowing patients and families to bypass costly middlemen fees through direct-to-patient (DTP) sales. There are common-sense, free-market solutions that voters are aligned on, and we urge the Trump administration and Congress to follow this direction when considering future health care reforms.

We commend President Trump for recognizing the importance of empowering patients, steering subsidies away from insurance companies, and unleashing choice and competition to lower costs and improve health outcomes.